This study is designed to compare TRV130 to placebo and morphine to learn about its effects on pain relief and side effects.
This study will explore the pharmacokinetics, pharmacodynamics (PD), safety and tolerability of TRV130.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
30
TRV130 1.5 mg IV x 1 dose
TRV130 3 mg IV x 1 dose
TRV130 4.5 mg IV x 1 dose
CRI Lifetree
Salt Lake City, Utah, United States
Cold Pain Test
Time frame: 8 hours postdose
Ventilatory Response to Hypercapnia
Time frame: 4 hours postdose
Pupillometry
Time frame: 8 hours postdose
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Morphine 10 mg IV x 1 dose
Dextrose 5% in water IV x 1 dose